Physician

Adel Shamsul Haque, M.D.

According to 2025 Medicare claims, Adel Haque, M.D. (NPI: 1760913511) practices dermatology in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Lehigh, PA. This provider's primary affiliated billing organization is PENNSYLVANIA DERMATOLOGY PARTNERS INC (NPI: 1023382918; TIN: 454600640) and primary practice location at 18062-1741.

Haque's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 832 traditional Medicare patients, billed 3,716 HCPCS/CPT codes, and received $618,259 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 695 prescription claims across 312 beneficiaries totaling $406,103 in drug costs, led by Otezla (Apremilast). Open Payments data shows 437 records totaling $239,938. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $163 to $406,103. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	228	1,006	$77,859
2022	622	4,214	$516,237
2023	907	4,549	$580,550
2024	832	3,716	$618,259

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	16	$163
2018	20	36	$1,720
2019	27	42	$28,086
2020	21	43	$24,063
2021	208	486	$117,001
2022	427	1,224	$586,462
2023	382	1,079	$802,455
2024	312	695	$406,103

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	357	437	$481
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	314	426	$306
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	209	306	$86
17000	Destruction of precancer skin growth, 1 growth	179	240	$36
17003	Destruction of precancer skin growth, 2-14 growths	158	1,046	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Otezla	Apremilast	13	390	$63,548
Clobetasol Propionate	Clobetasol Propionate	87	2,705	$4,776
Ketoconazole	Ketoconazole	51	1,403	$984
Imiquimod	Imiquimod	31	1,035	$876
Metronidazole	Metronidazole	24	740	$794

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	437	$239,938	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adel Shamsul Haque, M.D.?

Tedicare shows public-source Medicare data for Adel Shamsul Haque, M.D. (NPI 1760913511), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adel Shamsul Haque, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adel Shamsul Haque, M.D.?

Adel Shamsul Haque, M.D. is linked to PENNSYLVANIA DERMATOLOGY PARTNERS INC (billing NPI 1023382918) in the available physician profile data.

Does Adel Shamsul Haque, M.D. have Open Payments data?

Adel Shamsul Haque, M.D. has 437 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.